about
High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.Identification of isocitrate dehydrogenase 1 as a potential diagnostic and prognostic biomarker for non-small cell lung cancer by proteomic analysis.LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinomaGenetic landscape of esophageal squamous cell carcinoma.Phosphorylation of mutationally introduced tyrosine in the activation loop of HER2 confers gain-of-function activity.Development and validation of clinical diagnostic models for the probability of malignancy in solitary pulmonary nodules.Combination of platelet count and mean platelet volume (COP-MPV) predicts postoperative prognosis in both resectable early and advanced stage esophageal squamous cell cancer patientsAJUBA promotes the migration and invasion of esophageal squamous cell carcinoma cells through upregulation of MMP10 and MMP13 expression.Folate receptor-positive circulating tumor cells as a novel diagnostic biomarker in non-small cell lung cancer.The high expression instead of mutation of p53 is predictive of overall survival in patients with esophageal squamous-cell carcinoma: a meta-analysis.Exosomes: New players in cancer (Review).Immunohistochemical prognostic markers of esophageal squamous cell carcinoma: a systematic review.MicroRNA-99a/100 promotes apoptosis by targeting mTOR in human esophageal squamous cell carcinoma.Isocitrate dehydrogenase 1 is a novel plasma biomarker for the diagnosis of non-small cell lung cancer.TGF-β-induced NKILA inhibits ESCC cell migration and invasion through NF-κB/MMP14 signaling.Postoperative survival of EGFR-TKI-targeted therapy in non-small cell lung cancer patients with EGFR 19 or 21 mutations: a retrospective study.[Effectiveness of tyrosine kinase inhibitors against non-small cell lung cancer patients with postoperative recurrence harboring uncommon EGFR mutations].Xerophilusin B induces cell cycle arrest and apoptosis in esophageal squamous cell carcinoma cells and does not cause toxicity in nude mice.Primary and acquired EGFR T790M-mutant NSCLC patients identified by routine mutation testing show different characteristics but may both respond to osimertinib treatment.Prognostic value of PD-L1 in esophageal squamous cell carcinoma: a meta-analysis.PD-L1 expression on tumor cells associated with favorable prognosis in surgically resected esophageal squamous cell carcinomaOverexpression Is Associated With Tumor Progression and Poor Survival in Colorectal CancerKnockdown of KLF5 promotes cisplatin-induced cell apoptosis via regulating DNA damage checkpoint proteins in non-small cell lung cancerMiRNA expression profile reveals a prognostic signature for esophageal squamous cell carcinomaGADD45B as a Prognostic and Predictive Biomarker in Stage II Colorectal Cancer[Cost-effectiveness of lung cancer screening worldwide: a systematic review]
P50
Q33827629-4FEFDB62-F188-4DF4-AE51-E97FA1DEC2E3Q34069325-4C74B22C-CB8A-4860-AF3A-E4945ED7C04AQ34431243-0EBBA002-38D2-4F0A-86BE-B9AB8CE844B8Q34434773-E15E0C5D-187A-4121-85EF-6A18A0284F89Q35325158-6FB2A842-5D22-4D85-8F6A-20FD023D8434Q36439356-36F78223-32D4-4DEC-9A8E-021351C0350CQ37188178-4D392060-28ED-4A49-9FAD-A0563D0385E6Q37392726-930AC852-2011-42DF-B19B-B135FF437110Q37474373-A87C1450-E531-42DE-A0A1-3293B83B073AQ37609474-519D636D-740B-4C12-91F7-A7EF12DF074AQ39382436-0F6AF6BD-D61C-4895-ACAF-262908A60053Q41451463-AEFCAA40-D179-4F46-9134-466308D8BA23Q43485323-23E5ADBD-2D52-4BD0-8C4A-07BC88A044D0Q43746294-3AEED252-70CF-43B3-8C3B-1960B5447621Q48145747-C9B20D85-A58D-4523-8FFC-AC111131E698Q48352608-0FD60C38-80D2-4A89-ACE9-26A125913544Q50071955-21ED4CE3-4303-4AC2-9F61-56C0B42DE887Q53647460-34FC0255-15A2-43D2-957A-ACED887FF52EQ54122042-17639378-6345-4C94-8655-8FE432E13103Q55416061-A03D00A3-5E08-4DBD-8D25-ADAF4B46E853Q57184609-3D80D9BE-ACF6-458D-A1EA-EBFFAF374D4BQ60956607-5EA57591-FEAA-4F6D-A597-1D66CA1A01B0Q64068276-0E3E754E-3669-463E-AB47-ADDA8DEC8A40Q87760117-AAEC7755-A86C-4667-BC7A-F63F22550599Q90369580-8F2C7A77-5582-4962-9B15-C7889F7140AFQ91461820-27DCE428-FEC0-4595-9AFF-B27DE1B1F298
P50
description
researcher ORCID ID = 0000-0002-0501-9814
@en
wetenschapper
@nl
name
Yi-Bo Gao
@ast
Yi-Bo Gao
@en
Yi-Bo Gao
@es
Yi-Bo Gao
@nl
type
label
Yi-Bo Gao
@ast
Yi-Bo Gao
@en
Yi-Bo Gao
@es
Yi-Bo Gao
@nl
prefLabel
Yi-Bo Gao
@ast
Yi-Bo Gao
@en
Yi-Bo Gao
@es
Yi-Bo Gao
@nl
P1153
54964687600
P31
P496
0000-0002-0501-9814